ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

New ESA Label Maintains 12 g/dL

November 9, 2007

Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials

February 24, 1989

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

NCI New Advisory Group Named On special Populations

June 25, 1999

Animal Problems May Stop NIC Construction Grant To city Of Hope

September 13, 1985

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996